CME Group Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 02/07/2020   Download
SEC Document
SEC Filing

On and effective as of February 5, 2020, the Board of Directors (the “Board”) of the Company amended and restated the Company’s Fourteenth Amended and Restated Bylaws (as so amended and restated, the “Bylaws”), to modify the nomination process for Class B Directors (as defined in the Bylaws). As provided in the Bylaws, in connection with the 2021 annual meeting of shareholders and at each annual meeting thereafter, nominees for each class of Class B Directors will include eligible nominees selected by the Board’s Nominating and Governance Committee and nominees who satisfy the existing requirements for write-in nominees. As a consequence, the Class B Nominating Committees (as defined in the Bylaws) will be eliminated as of the 2020 annual meeting of shareholders.

As provided by the Bylaws, the nominations of Class B Directors for the 2020 annual meeting of shareholders, to be held May 6, 2020, were selected by the existing, applicable Class B Nominating Committees. There will not be an election at the 2020 annual meeting of shareholders for new Class B Nominating Committees.

Additionally, the Bylaws formalize the combination of the Nominating and Governance Committees of the Board into a single committee.